# Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

> **NCT05915897** · — · TERMINATED · sponsor: **Sanguine Biosciences** · enrollment: 6 (actual)

## Conditions studied

- Chronic Granulomatous Disease

## Interventions

- **DIAGNOSTIC_TEST:** Specimen Donation

## Key facts

- **NCT ID:** NCT05915897
- **Lead sponsor:** Sanguine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-23
- **Primary completion:** 2024-03-25
- **Final completion:** 2024-03-25
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Unable to recruit subjects due to disease rarity
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05915897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05915897, "Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05915897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*